MRC Epidemiology Unit

 

Estimating the Population Benefits of Blood Pressure Lowering: A Wide-Angled Mendelian Randomization Study in UK Biobank.

Higgins H, Mason AM, Larsson SC, Gill D, Langenberg C, Burgess S

Journal of the American Heart Association. Aug 2021

(DOI : 10.1161/JAHA.121.021098)

---

High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease.

Zuber V, Gill D, Ala-Korpela M, Langenberg C, Butterworth A, Bottolo L, Burgess S

International Journal of Epidemiology. Sep 2020

(DOI : 10.1093/ije/dyaa216)

---